AnalystsSam EiberSam Eiber's Stock Forecasts
AnalystsSam Eiber
Analyst Ranking
Bottom 11%
#4710 out of 5267 analysts
Average Return
-10.02%
Win Rate
29%4 out of 14
Risk vs Reward
Poor
Good
Sam Eiber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Establishment Labs Holdings IncESTA | +16.08% | $60.51 | $70.24 | 2025-11-05 - 2026-05-04 | Strong Buy |
Establishment Labs Holdings IncESTA | +12.51% | $62.43 | $70.24 | 2026-04-29 - 2026-05-04 | Strong Buy |
Evolus IncEOLS | +9.84% | $5.08 | $5.58 | 2026-01-22 - 2026-05-04 | Strong Buy |
Establishment Labs Holdings IncESTA | +9.77% | $63.99 | $70.24 | 2025-11-14 - 2026-05-04 | Strong Buy |
Sam Eiber Analyst Color
Get additional color on Sam Eiber's coverage of popular stocks
Sam Eiber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Establishment Labs Holdings IncESTA | 5 | Strong Buy | $88.00 | +25.28% | Reiterates | 6 days ago |
Apyx Medical CorpAPYX | 1 | Strong Buy | $6.00 | +110.53% | Upgrades | 2 months ago |
Sbc Medical Group Holdings IncSBC | 1 | Strong Buy | $8.00 | +143.90% | Initiates Coverage On | 2 months ago |
Evolus IncEOLS | 5 | Strong Buy | $13.00 | +132.97% | Reiterates | 2 months ago |
Merit Medical Systems IncMMSI | 1 | Strong Buy | $107.00 | +72.55% | Initiates Coverage On | 3 months ago |
Inmode LtdINMD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.